GLYC OBI

Live / Registered — Registered (as of 19 Aug 2025)

What this means for you

Registered since 19 Aug 2025. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
98289547
Registration number
7896178
Mark type
Design + words
Filed
29 Nov 2023
Published for opposition
01 Jul 2025
Registered
19 Aug 2025
Attorney of record
Ran He

Goods and services

  • Class 001 — Chemicals: Carbide; Cellulose; Glycogen; Glycoprotein; Sulfides; Active chemical ingredients for use in the manufacture of anti-cancer drugs; Adjuvants, other than for medical or veterinary purposes; Antioxidants for use in the manufacture of pharmaceuticals; Biochemical catalysts; Biological preparations for use in industry and science; Carbonic hydrates; Chemical additives for use in the manufacture of pharmaceuticals; Chemical preparations for scientific purposes, other than for medical or veterinary use; Chemical substances for analyses in laboratories, other than for medical or veterinary purposes; Fatty acids for use in pharmaceutical; Polymers and polymeric additives for use in the manufacture of pharmaceutical preparations, plastics, cosmetics, personal care products, coatings, adhesives, and lubricants; Protein in raw material form for scientific and medical research; Proteins for use in manufacture; Proteins for use in the manufacture of drugs
  • Class 005 — Pharmaceuticals: Immunostimulants; Vaccines; Adjuvants for medical purposes; Anti-cancer preparations; Biological preparations for the treatment of cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer to be prevented or treated; Chemical reagents for medical or veterinary purposes; Enzyme preparations for medical purposes; Enzymes for medical purposes; Ferments for pharmaceutical purposes; Hormones for medical purposes; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the treatment and prevention of cancer; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Preparations of microorganisms for medical purposes; Tumor suppressing agents
  • Class 042 — Scientific and technological services: Biological research; Biological research and analysis; Chemical analysis; Chemical research; Chemical research and analysis; Chemical research services; Medical and scientific research in the field of cancer treatment and diagnosis; Medical research; Medical research in the field of oncology; Medical research services; Medical research services in the field of cancer; Pharmaceutical research and development; Providing information about medical research in the field of cancer, oncology; Providing laboratory research services in the field of gene expression, namely, cancer biology; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Scientific laboratory services; Scientific research; Scientific research and development; Scientific research in the field of genetics; Technical research in the field of pharmaceutical studies
  • Class 044 — Medical, beauty and agricultural services: Administering vaccines to patients; Alternative medicine services; Cancer screening services; Cultured cell bank services for medical transplantation; Health care; Health care services for treating cancer; Health assessment services; Health counselling; Human tissue bank services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical assistance; Medical screening; Medical treatment using cultured cells; Nursing, medical; Occupational therapy; Providing health information in the field of cancer prevention and treatment; Providing information in the field of cancer prevention, screening, diagnosis and treatment; Regenerative medicine services; Remote monitoring of medical data for medical diagnosis and treatment; Telemedicine services

Owner

Prosecution history

  • 19 Aug 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 19 Aug 2025 — REGISTERED-PRINCIPAL REGISTER
  • 01 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 01 Jul 2025 — PUBLISHED FOR OPPOSITION
  • 25 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 14 Feb 2025 — CASE RETURNED TO EXAMINATION
  • 14 Feb 2025 — NOTICE OF ALLOWANCE CANCELLED
  • 14 Feb 2025 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
  • 14 Feb 2025 — PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
  • 13 Feb 2025 — ASSIGNED TO PETITION STAFF
  • 03 Jan 2025 — TEAS PETITION TO AMEND BASIS RECEIVED
  • 01 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 06 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 06 Aug 2024 — PUBLISHED FOR OPPOSITION
  • 17 Jul 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

View this trademark record on Marksy